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Abstract
In biological systems that undergo processes such as differentiation, a clear concept of progression exists. We present a
novel computational approach, called Sample Progression Discovery (SPD), to discover patterns of biological progression
underlying microarray gene expression data. SPD assumes that individual samples of a microarray dataset are related by an
unknown biological process (i.e., differentiation, development, cell cycle, disease progression), and that each sample
represents one unknown point along the progression of that process. SPD aims to organize the samples in a manner that
reveals the underlying progression and to simultaneously identify subsets of genes that are responsible for that progression.
We demonstrate the performance of SPD on a variety of microarray datasets that were generated by sampling a biological
process at different points along its progression, without providing SPD any information of the underlying process. When
applied to a cell cycle time series microarray dataset, SPD was not provided any prior knowledge of samples’ time order or
of which genes are cell-cycle regulated, yet SPD recovered the correct time order and identified many genes that have been
associated with the cell cycle. When applied to B-cell differentiation data, SPD recovered the correct order of stages of
normal B-cell differentiation and the linkage between preB-ALL tumor cells with their cell origin preB. When applied to
mouse embryonic stem cell differentiation data, SPD uncovered a landscape of ESC differentiation into various lineages and
genes that represent both generic and lineage specific processes. When applied to a prostate cancer microarray dataset,
SPD identified gene modules that reflect a progression consistent with disease stages. SPD may be best viewed as a novel
tool for synthesizing biological hypotheses because it provides a likely biological progression underlying a microarray
dataset and, perhaps more importantly, the candidate genes that regulate that progression.
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Introduction
Biological processes of development, differentiation and aging are
increasingly being described by the temporal ordering of highly
orchestrated transcriptional programs [1]. When such processes are
analyzed with gene expression microarrays at specified time points, a
variety of computational methods are available to identify which
genes vary and how they vary across part or all the time points
[2,3,4,5,6]. However, when microarray samples of a biological
process are available but their ordering is not known, fewer methods
are available to recover the correct ordering, especially when the
underlying process contains branchpoints, as occurs in the differen-
tiation from hematopoietic stem cells to myeloid and lymphoid
lineages. We present a novel method, referred to as Sample
Progression Discovery (SPD), to discover the progression among
microarray samples, even if the progression contains branchpoints. In
addition, SPD simultaneously identifies genes that define the
progression. SPD can be used to generate biological hypotheses
about a progressive relationship among samples, and the genes that
serve as key candidate regulators of the underlying process.
Recovery of an ordering among unordered objects has been
studied in a variety of contexts. In computer vision, images taken
from random viewpoints and angles were ordered for the purpose
of multi-view matching [7], where the ordering was based on
predefined features that are invariant to different viewpoints. In
genetics, spanning trees were applied to reconstruct genetic linkage
maps [8], which was an ordering of genetic markers. Using gene
expression data of a small set of preselected genes, phylogenetic
trees were constructed to study cancer progression among
microarray cancer samples [9,10]. Microarray samples were also
ordered by a traveling salesman path from combinatorial
optimization theory, but feature selection was not discussed
[11,12]. Although these methods proved useful in the recovery
of an ordering from unordered objects, their direct applications
cannot address the challenges of extracting progression and
differentiation hierarchy from microarray gene expression data.
Algorithms in [7,11,12] assume linear ordering of unordered
objects, and therefore are not able to reveal potential branch-
points. Furthermore, most existing methods order samples based
on carefully designed or preselected features. However, in
microarray gene expression data, meaningful gene features are
usually not known a priori. One important aspect of SPD is its
feature selection ability. Assuming the underlying progression can
be reflected by gradual expression changes of subsets of genes,
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progression, and hypothesizes that the common progression is
biologically meaningful.
The SPD framework, as depicted in Figure 1, discovers
biological progression from gene expression microarray data using
four steps: (1) cluster genes into modules of co-expressed genes, (2)
construct minimum spanning tree (MST) for each module, (3)
select modules that supports common MSTs, and (4) reconstruct
an overall MST based on all the genes of all the selected modules.
Gene clustering is needed to reduce the number of gene expression
patterns to be tested. We introduce an iterative consensus k-means
algorithm to derive coherent gene modules, where genes within
each module are highly co-expressed. For each gene module, a
minimum spanning tree (MST) is constructed [13], where the
nodes of the MST are the microarray samples and the edges are
weighted by the distance between samples’ gene expression
profiles. Because a MST connects samples using the minimum
number of edges and minimum total edge weights, it tends to
connect samples that are more similar to each other. Therefore,
we use the MST to describe the progression among the samples,
defined by the gradual change of the corresponding gene module.
The progression is not necessarily linear, and can contain
branching points.
SPD then performs feature selection by evaluating the statistical
concordance between each gene module and each MST. We
Author Summary
We present a novel computational approach, Sample
Progression Discovery (SPD), to discover biological pro-
gression underlying a microarray dataset. In contrast to the
majority of microarray data analysis methods which
identify differences between sample groups (normal vs.
cancer, treated vs. control), SPD aims to identify an
underlying progression among individual samples, both
within and across sample groups. We validated SPD’s
ability to discover biological progression using datasets of
cell cycle, B-cell differentiation, and mouse embryonic
stem cell differentiation. We view SPD as a hypothesis
generation tool when applied to datasets where the
progression is unclear. For example, when applied to a
microarray dataset of cancer samples, SPD assumes that
the cancer samples collected from individual patients
represent different stages during an intrinsic progression
underlying cancer development. The inferred relationship
among the samples may therefore indicate a trajectory or
hierarchy of cancer progression, which serves as a
hypothesis to be tested. SPD is not limited to microarray
data analysis, and can be applied to a variety of high-
dimensional datasets. We implemented SPD using MA-
TLAB graphical user interface, which is available at http://
icbp.stanford.edu/software/SPD/.
Figure 1. Sample Progression Discovery (SPD) framework.
doi:10.1371/journal.pcbi.1001123.g001
Sample Progression Discovery (SPD)
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as the number of MSTs that are concordant with both of the two
modules. If two modules are concordant with the same MST,
these two modules share progression similarity, because their
gradual changes support a common progression order among the
microarray samples. A noteworthy point here is that modules that
are concordant with the same MST are not necessarily correlated
with each other; hence SPD is able to identify similarities that may
be missed by correlation or regression-based analyses [14,15,16]. If
there exist multiple modules that are concordant with a common
set of MSTs, these modules support a common progression, which
is likely to be biologically meaningful. SPD selects modules that
share progression similarity, and constructs an overall MST based
on all the genes within the selected modules. The overall MST and
the selected modules serve as the basis for generating hypotheses of
the underlying biological process and its regulators.
To demonstrate the potential of SPD to reveal biological
processes underlying microarray samples, we applied it to a variety
of microarray datasets, each of which was associated with a known
biological progression. In each case, the known progression was
hidden from SPD, and was used to validate the progression
discovered by SPD. First, SPD was applied to a time series
microarray dataset of the cell cycle. SPD successfully recovered the
correct time order of the samples and identified many genes that
have been associated with the cell cycle. When applied to B-cell
differentiation data, SPD recovered the correct order of different
stages of normal B-cell differentiation, and identified the linkage
between preB-ALL tumors and their preB cell of origin. SPD was
applied to a mouse embryonic stem cell differentiation dataset,
where SPD uncovered a landscape of ESC differentiation into
various lineages and genes that represent both generic and lineage
specific processes. When applied to a prostate cancer microarray
dataset, SPD identified gene modules that reflect a progression
consistent with disease stages. All of these applications of SPD are
presented in the following sections and, collectively, show that
SPD may be best viewed as a novel tool for synthesizing biological
hypotheses, because it provides a likely biological progression
across microarray samples and, perhaps more importantly, the
candidate genes that regulate the progression. We implemented
SPD using MATLAB graphical user interface. Our software is
available at http://icbp.stanford.edu/software/SPD/.
Results
SPD recovers temporal information of cell cycle time
series data
Microarray time series data of the cell cycle were used to
evaluate the performance of SPD. Information on the temporal
sample order and cell-cycle regulated genes were not provided to
SPD. We hypothesized that SPD would recover the underlying
biological progression (in this case, the cell cycle) and identify the
genes associated with that progression. Five cell cycle time series
gene expression datasets in [17] were independently analyzed by
SPD. Here we present the SPD analysis on the series with the
largest number of samples. SPD analysis of the other time series
can be found in Supplement Text S1.
The input of SPD was a gene expression data matrix of 3196
high variance genes across 17 unordered samples from only one
cell cycle. The SPD analysis was deliberately limited to samples
in one cell cycle to avoid the possibility that SPD would order the
samples using the cyclic behavior of cell-cycle regulated genes
that can be easily observed across multiple cell cycles. SPD
clustered the 3196 high variance genes into 154 modules of
co-expressed genes, using an iterative consensus k-means approach
(see Methods). One MST was constructed for each module. Each
MST represented a possible progression order of the samples
based on the expression of its corresponding module. Then, a
progression similarity matrix was constructed to quantify the
similarity between pairs of modules. The (u,v) element of the
progression similarity matrix was defined as the number of MSTs
concordant with both modules u and v. (see Methods). The
progression similarity matrix is shown in Figure 2(a), and a
magnified portion is shown in Figure 2(b) to highlight nine
modules (3, 10, 17, 24, 4, 30, 6, 5 and 20) that are regarded as
similar in terms of progression. In the last step of SPD, the nine
modules with the highest progression similarity were combined to
construct an overall MST. The overall MST was visualized using
high-dimensional embedding, shown in Figure 2(c), and revealed a
near perfect restoration of the sample order. Interestingly, when
we examined the MSTs constructed from each of the nine
modules, we did not recover the correct order because we were
essentially projecting the progression into a lower dimensional
space. To demonstrate the value of the overall MST versus the
individual-module MSTs for restoring the sample order, we
applied a distance metric called topological overlap measure
(TOM) [18] to evaluate the distance between the MSTs and the
true sample order. Table 1 shows that the overall MST based on
combining the nine modules (the first row) produced a more
accurate sample order than the MSTs derived from the individual
modules.
Next, we compared SPD to the commonly used hierarchical
clustering analysis of the dataset described above. After all, a MST
can be regarded as a hierarchical clustering tree with single linkage
[19]. The main difference between hierarchical clustering and the
SPD framework is that SPD selects gene modules that share
progression similarity, and reconstructs an overall MST based on
the selected modules. To illustrate the significance of SPD’s feature
selection ability, we performed single linkage hierarchical
clustering based on all the 3196 genes, which is equivalent to
constructing a MST based on all these genes. The resulting
dendrogram did not recover the correct sample order, as shown in
Figure 2(d). Moreover, the TOM distance between the hierarchi-
cal clustering tree and the true sample order was much larger than
that from SPD, as shown in Table 1 (last row). This analysis
demonstrates the importance of SPD’s feature selection ability.
To evaluate the robustness of SPD, we performed bootstrap
analysis on the cell cycle microarray dataset. In each of the 100
bootstrap iterations,90%of the 3196 geneswererandomly selected.
SPD was applied to each bootstrapped dataset separately. In each
bootstrapped dataset, the clustering step might generate different
gene modules that lead to different progression-related modules and
a different overall MST. However, the overall MSTs were
consistent across the bootstrapped datasets. The TOM distance
was used to evaluate the distance between the 100 SPD results and
the true sample order. The mean TOM distance was 5:36+3:37.
The standard deviation of the TOM distance appeared to be
comparable to the mean due to the statistical properties of TOM.
To evaluate the statistical significance of this result, we performed
random permutation analysis. We generated 1000 random MSTs,
and computed the TOM distance between random MSTs and the
true sample order. The mean of the random TOM distance was
59+8, which is substantially larger than the TOM distances
obtained in the bootstrap analysis, indicating the robustness of SPD.
In addition, we examined the diameters of the random MSTs,
where the diameter is defined as the number of edges in the shortest
path between the most distantly separated pair of nodes. The mean
diameter of a random 17-node MSTwas 7:7+1:4. The diameter of
the SPD result in Figure 2(c) was 15. The probability of obtaining
Sample Progression Discovery (SPD)
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SPD result was statistically significant.
The mean expression profiles of the nine modules are shown in
Figure 2(e). Some of these modules are uncorrelated (i.e., modules
10 and 30 have a correlation coefficient of 20.06), but SPD
identified them as similar in terms of progression. Figure 2(f) shows
the mean expression profiles of the nine modules across all three
cell cycles that were provided in the original dataset. Here, we can
observe that some of the identified modules are cyclic. Gene sets in
the Molecular Signatures Database (MSigDB) [20] were used to
Figure 2. SPD applied to a cell cycle gene expression dataset. (a) Based on an expression matrix of 3196 genes for 17 unordered samples
from one cell cycle, SPD derived 154 modules and a progression similarity matrix between them. (b) Zoomed-in view of the progression similarity
matrix highlights nine modules that are similar in terms of progression. (c) SPD constructed an overall MST to describe the common progression
supported by the nine modules, showing a near perfect reconstruction of the correct time order. (d) Hierarchical clustering analysis did not recover
the correct time order. In (c) and (d), Samples were color-coded according to the time points (t, hours), when the samples were taken. Blue
corresponds to earlier time points; red corresponds to later time points. (e) The average expressions of the nine modules across the 17 time points
show that, some of the nine modules were uncorrelated, i.e., modules 10 and 30, but SPD identified them as similar in terms of progression. (f) The
mean expressions of the nine modules across all three cell cycles. The number in the parentheses above each plot is the number of genes in the
corresponding module.
doi:10.1371/journal.pcbi.1001123.g002
Sample Progression Discovery (SPD)
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expected, these modules included many genes that have been
associated previously with the cell cycle. For example, module 10
was highly enriched (p*10{7, hypergeometric test for gene set
enrichment) for genes that are targets of the E2F cell cycle
transcription factor family. A likely explanation for the presence of
the acyclic modules is that they represent the experimental
perturbation that initially synchronized the cells. In the cell cycle
microarray experiments, the measured population of cells were
first synchronized, and then released. This initializing synchroni-
zation condition is a cellular perturbation that may take several
cell cycles to decay away.
SPD recovers stages of B-cell differentiation
We applied SPD to a B-cell differentiation dataset [21], in
which 9365 genes were measured for 44 samples across 5 normal
differentiation stages and 1 malignant stage: 7 hematopoietic stem
cells (HSC), 7 common lymphoid progenitors (CLP), 7 proB cells,
7 preB cells, 7 Immature B cells (IM), 5 more terminally
differentiated B cells (1 naive B cell, 1 centroblast CB, 1 centrocyte
CC, 1 memory B cell, 1 CD19+cell), and 4 preB-ALL cancer
samples. Without providing SPD any information on the known
differentiation stages of the sample, we tested whether SPD could
recover the progression underlying this dataset, which is known to
be: HSC, CLP, proB, preB, IM, naiveB/CB/CC/memoryB/
CD19+. Another objective was to determine whether the preB-
ALL would be grouped near its preB cell origin.
SPD selected ten gene modules (composed of 2388 genes in
total) which supported a common progression. Based on these
modules, an overall MST was constructed to describe the
underlying progression. After obtaining the overall MST, samples
were color-coded according to their known classifications, as
shown in Figure 3(a). The identified progression was consistent
with the known stages of normal B-cell differentiation, except for a
missing link between immature B cells and the next more
differentiated B cells (naiveB/CB/CC/memoryB/CD19+). The
link between preB-ALL cancer samples and their cell origin
(normal preB cells) was identified.
The link between immature B cells and more differentiated B
cells was missing, partly because MSTs do not allow for cycles. We
hypothesized that if we removed the cancer samples and the
outliers that are grouped next to the cancer samples, the missing
link would be restored. To test this, we removed the cancer
samples and the outliers, and performed SPD analysis again. The
resulting MST was consistent with the stages of normal B-cell
differentiation, as shown in Figure 3(b).
Annotations of the selected modules can be found in Supplement
Text S1. Some modules contained genes that relate to B-cell
differentiation but are generic in their function. Examples include
proliferation genes (p~3|10{12, hypergeometric test), which are
highly expressed in germinal center B-cells that are undergoing rapid
expansion, but down-regulated at other stages. SPD also recovered
modules of genes that are specific to B-cell differentiation. These were
enriched in genes that are known markers of, or mechanistically
related to, B-cell differentiation such as CD19, CD20, CD79 (B-cell
receptor), and the master transcription factors PAX5 and SP140. We
also observed enrichment (p~2|10{7)f o rg e n e si nt h eB - c e l l
receptor (BCR) pathway, which is the key signaling pathway
governing the maturation of B cells.
SPD reveals landscape of embryonic stem cell
differentiation
The two examples in the previous subsections show that SPD is
able to recover non-branching progression patterns. In this
subsection, we demonstrate SPD’s ability to recover branched
progression patterns, using an embryonic stem cell differentiation
dataset. Pluripotent embryonic stem cells (ESCs) are capable of
differentiating into all cellular lineages in the development of a
mature organism. We applied SPD to a dataset of 44 samples of
mouse ESCs and their progeny which had been induced to
differentiate into several lineages by specific interventions, as well
as several differentiated cell types. The interventions included
knockdown of Pou5f1/Oct4 (leading to differentiation to tropho-
blasts), induction of GATA6 (differentiation to endoderm lineage),
treatment with N2B27 medium (differentiation to neural lineages),
and all-trans retinoic acid (RA) induction of embryonic carcinoma
cells to cause differentiation [22]. The data included time series
along each lineage of cells.
When SPD was applied to this dataset, information on the
interventions and the temporal order of the samples were hidden
from the algorithm. SPD identified 35 modules that supported a
common progression, which revealed a landscape of ESC
differentiation into the various lineages. Remarkably, samples
were perfectly ordered in time, with progressively later stages of
differentiating cells radiating outwards from a core cluster of ESC
samples, as shown in Figure 4. A subset of induced pluripotent
(iPS) cells clustered as a group, in close proximity to ESC samples.
Trophoblast stem cells grouped with the trophoblast differentia-
tion lineage, while stromal and fibroblast cell lines were correctly
clustered with mature fibroblasts. The identified modules provided
a fine-scale view of expression changes along each lineage. The
identified modules included ones which changed in a similar
fashion during differentiation of all cell types from ESCs, as well as
ones that were uniquely associated with specific lineages. We
annotated modules by comparison to known gene sets, and by
examining the relationship between their constituent genes using
Ingenuity Pathways Analysis (IPA). Annotation results are
available in Supplement Text S1.
Module 228 was progressively induced in all differentiating
lineages, as shown in Figure 4, and was enriched for genes that are
targets of Suz12 and Ezh1. The latter are members of the Polycomb
complex that functions in maintaining self-renewal in ESCs. Thus
induction ofthis module is consistent with a generalloss of self-renewal
potential in specialized cell types. Similarly, modules 54 and 55
(enriched for Myc targets and genes involved in Oct4 maintenance of
pluripotency) were both down-regulated in each differentiating
Table 1. The topological overlap measure between extracted
sample progression patterns and the true time order.
TOM network distance
SPD 4.33
Module 3 MST 17.33
Module 4 MST 19.33
Module 5 MST 24.00
Module 6 MST 18.33
Module 10 MST 20.17
Module 17 MST 35.67
Module 20 MST 45.57
Module 24 MST 29.33
Module 30 MST 26.00
single linkage HC 42.50
doi:10.1371/journal.pcbi.1001123.t001
Sample Progression Discovery (SPD)
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s t r o n g e s tm u t i n go fe x p r e s s i o no ccurring along the trophoblast
lineage. One module (329) was highly enriched for genes that share
a common pattern of histone H3K27 methylation, and that are
targets of the Ezh2/Polycomb complex. Notably these genes were
progressively down-regulated in all branches except the neural
lineage. This suggests particular subsets of Polycomb targets that are
regulated in a tissue-specific manner. In the opposite direction,
module 65 genes were strongly induced in trophoblast differentiation,
and more modestly in the other branches. This module contained
numerous genes that are induced by shRNA knockdown of the
pluripotency factor Sox2, as well as apoptosis-related genes.
Intriguingly, this module included many genes involved in integrin
signaling and endocytosis signaling. Thus its strong induction in
differentiating trophoblasts (which are involved in placental implan-
tation of the embryo) is consistent with their critical invasive
properties, and the SPD result identifies genes that may be implicated
in this phenotype.
Two modules (3 and 123) were highly specifically regulated
along the trophoblast differentiation branch. IPA analysis of
module 3 indicated that this cluster of genes was highly enriched
with targets of tumor necrosis factor (TNF). This is concordant
with the fact that over-expression of TNFa induces differentiation
of ESC to trophoblasts. In the dataset analyzed with SPD,
trophoblast differentiation was induced by down-regulation of
Oct4. The overlap with TNF targets suggests that these two
mechanisms of induction share commonalities in the gene
expression changes involved in generation of trophoblasts from
ESC. Given the master-regulatory role of Oct4 in maintaining
pluripotency, one hypothesis is that induction of TNF effects
downstream changes in the Oct4 network, while at the same time
producing changes in transcription that lead specifically to
production of trophoblasts. Module 123 was annotated as
associated with cell motility genes. Again, this is consistent with
the invasive character of trophoblasts, and suggests genes that are
involved in mediating this behavior.
Figure 3. SPD applied to gene expression data of B-cell differentiation. (a) Analysis based on all samples in this dataset. (b) Analysis of
normal samples, with cancer samples and outliers next to cancer samples removed. Samples are color-coded according to their classification: HSC
(violet), CLP (blue), proB (light blue), preB (green), immature (yellow), naiveB/CB/CC/memoryB/CD19+ (red), preB-ALL (brown). Circles are added to
highlight each class of samples.
doi:10.1371/journal.pcbi.1001123.g003
Sample Progression Discovery (SPD)
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differentiated cell types generated by targeted manipulations of
ESCs. The differentiation landscape identified by SPD shows
underlying progressive changes in gene expression that represent
both generic processes as well as ones specific to particular
lineages. The genes that constitute the modules supporting the
differentiation tree represent targets for further investigation as to
their role in organism development.
SPD reveals stages of prostate cancer progression
We applied SPD to a prostate cancer microarray dataset [23]. This
dataset contains a total of 163 patient samples, including tissue of
normal prostate from organ donors, normal prostate tissue adjacent to
the prostate tumor (NAP), primary prostate tumor samples, and
metastatic samples. When SPD was applied to this dataset, the clinical
information on the samples were hidden from the algorithm.
In this dataset, the average correlation between genes was small,
consequently, SPD generated modules that contained a small
number of genes. We excluded modules that contained less than 5
genes, leaving 46 coherent modules for subsequent analysis. SPD
selected 12 modules (487 genes in total) with high progression
similarity and derived the tree structure shown in Figure 5(a).
Normal and metastatic samples were enriched at the left and right
ends of the tree. SPD produced a mixture of NAP and tumor
samples in the middle of the tree. A larger fraction of NAP samples
were closer to normal samples, and tumor samples were closer to
Figure 4. SPD applied to mouse embryonic stem cell differentiation data. SPD revealed a landscape of mouse embryonic stem cell
differentiation, where samples were perfectly ordered in time, with progressively later stages of differentiating cells radiating outwards from a core
cluster of ESC samples. Circles were added to highlight each lineage. Nodes were color-coded by the expression level of a gene module (blue means
low expression; green/yellow means medium; red means high expression). Module 228 was progressively induced in all differentiating lineages, and
was enriched for Suz12 and Ezh1 targets. Module 3, enriched by TNF targets, was highly specifically regulated along one lineage, the trophoblast.
doi:10.1371/journal.pcbi.1001123.g004
Sample Progression Discovery (SPD)
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reflects possible field effect [23], which suggested that normal
tissue adjacent to primary tumor is more similar to the primary
tumor than it is to normal tissues. The general trend in Figure 5(a)
reflected a progression consistent with disease stages. In addition,
we observed details that we did not expect: a few normal samples
were mixed with tumor samples; and the metastatic samples
appeared to form two branches.
To interpret the tree, we color-coded the nodes using the average
gene expression of each of the 12 modules, and observed three
expression patterns. Representative modules of the three patterns are
shown in Figure 5(b), (c) and (d). Color-codes of other modules are
available in Supplement Text S1. Module 2 and three other modules
are gradually down-regulated from normal to tumor and metastatic
samples, whereas module 32 and two other modules are gradually up-
regulated. Interestingly, we observed that the expression of module 19
and four other modules first increase from normal to tumor and then
gradually decrease in metastatic samples. Several modules show clear
difference between the two branches in the upper right corner, i.e.
Figures 5(c), (d) and several modules shown in Supplement Text S1.
The expressions of these modules indicate that the metastatic samples
can be further divided into two subtypes.
We used Gene Set Enrichment Analysis to annotate the
modules that are up-regulated in primary tumor while down-
regulated in both normal and metastatic samples. We noticed that
these modules overlapped with genes involved in metastasis in
several epithelial cancers (not just prostate studies). They may
reflect general processes underlying the epithelial-mesenchymal
transition and cell migration. Of note, one of the genes in this
module is CDH3, a member of the cadherin family that interacts
with CDH1. Targeted down-regulation of cadherins by RNA
interference has been demonstrated to induce cell migration.
However, up-regulation from normal to primary tumors followed
by down-regulation in metastases has not been commented upon
previously. We also applied IPA to the genes that comprised these
modules. The most significant interaction network centered
around genes involved in androgen and estrogen signaling, and
influenced by beta-estradiol. Although estradiol is the predomi-
nant sex hormone in females, it is also produced in males as a
metabolic product of testosterone. Androgen signaling generally
has a pro-survival effect in prostate cancers. Thus one possible
interpretation of the SPD result is that it reflects the fact that in
primary tumors, androgen signaling up-regulation confers a
selective advantage in the natural history of the tumor; but that
some metastases develop androgen-independence. A priori, from
gene expression profiles, it is unknown which metastases are
androgen-independent; hence SPD may be identifying both
androgen-independent samples, together with the genes whose
changes in expression drive the phenomenon.
Discussion
SPD is a new approach to infer progression among microarray
samples and identify genes that drive the progression. SPD
Figure 5. SPD applied to a prostate cancer dataset and derived a tree structure that describes the underlying progression. (a) Nodes
were color-coded according to their classification: normal, normal adjacent to tumor (NAP), tumor, metastatic samples (Mets). In (b), (c) and (d), nodes
were color-coded using the average expression of modules 2, 32 and 19, respectively, in order to show how the expression of these modules
gradually change during the progression.
doi:10.1371/journal.pcbi.1001123.g005
Sample Progression Discovery (SPD)
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been extensively applied to microarray analysis. The more
common machine learning algorithms that have been used to
analyze microarray data include unsupervised clustering [19,24],
supervised classification [25,26,27,28], and statistical tests for
differential expression [20,29]. Although these algorithms are
quite different from each other, they share a similar goal, which is
to identify differences between different sample groups, i.e. normal
vs. cancer. When applied to study a progressive biological process,
these methods essentially bin the process into stages and identify
differences between sample groups from consecutive stages of the
progression. SPD differs significantly in this regard. Instead of
assuming that samples in the same group are similar and focusing
on the differences between groups, SPD treats individual samples
as different points along an unknown biological progression, thus
has the potential to discover how samples progress both within and
across groups. As mentioned earlier, recovery of an ordering from
unordered samples has been studied in several fields, computer
vision, [7], genetic linkage analysis [8,9,10], microarray time series
[11,12]. However, due to lack of ways to automatically select
meaningful features, the direct application of these approaches
cannot address the challenges of extracting unknown progression
from microarray data. In contrast, SPD is unique in its ability to
simultaneously identify both the progression relationship among
samples and the genes that are associated with the progression,
without prior knowledge or manual gene selection.
SPD shares some similarities with bi-clustering, since both
methods attempt to simultaneously organize genes and samples.
However, the results of SPD and bi-clustering are quite different
from each other. Bi-clustering organizes genes into clusters, and
each gene cluster stratifies samples in a potentially different way.
In contrast, SPD has a module selection step which selects the
gene modules that are similar in terms of progression. The selected
modules support a common progression pattern among the
samples, defined by a single overall MST which is constructed
based on all the genes in the selected modules.
In SPD, we propose a new similarity measure, namely the
progression similarity. This measure evaluates the similarity
between gene modules based on whether they are concordant
with common progression patterns represented by MSTs. In
contrast to correlation and regression-based methods [14,15,16]
where the expression profiles of gene modules are directly
compared with each other, SPD evaluates progression similarities
between gene modules via MSTs. We have shown that modules
that are similar in SPD do not necessarily correlate with each
other; this demonstrates that SPD is able to identify similarities
that correlation and regression-based analyses may miss.
As demonstrated in the analysis of the cell cycle time series and
B-cell differentiation microarray data, SPD is able to discover the
biological progression underlying a microarray dataset, while
simultaneously selecting the genes that are known to be central to
this progression. When applied to these datasets, SPD was not
provided the information on the known ordering of the samples,
and instead derived the ordering in an unsupervised fashion.
Because the SPD-derived ordering is consistent with the time
order of the samples, time represents the strongest progression
signal, and the gradual shifts of the identified gene modules are
associated with the time series experiment. Enrichment of
transcription factors or pathways in the identified modules may
be hypothesized as key drivers of the progression, and subject to
further experimental validation. If the SPD-derived ordering were
different from the time order, the strongest progression signal
would be some factor other than time, which hints at other sources
of variations present in the time series data.
We view SPD as a hypothesis synthesis tool that may have
greatest utility when applied to a microarray dataset where the
underlying biological progression is unknown. For example, when
applied to cancer samples, SPD assumes that there is an intrinsic
progression underlying cancer development, and that the cancer
samples collected from individual patients represent different
stages in this progression. The inferred progression relationship
among the cancer samples may therefore indicate a trajectory or
hierarchy of cancer progression. Under this assumption, SPD
extracts the progression among cancer samples and gene modules
whose gradual shifts are associated with the progression, as
demonstrated on human prostate cancer samples. The identified
progression and gene modules form hypotheses to be validated.
SPD is not limited to microarray data analysis and can be applied
to a variety of high-dimensional datasets, including genomic,
proteomic and image-based data.
Methods
Iterative consensus clustering
Gene clustering reduces data dimension and noise. It is well
known that gene clustering is a difficult optimization problem with
many local minimums, and most clustering algorithms lack
consistency and reproducibility across multiple runs [30]. We
propose an iterative consensus k-means algorithm to derive
consistent coherent gene modules. Our algorithm is an iterative
divisive hierarchical clustering procedure. In every iteration, each
gene module from the previous iteration is divided into two
modules, until our stopping criterion is met. Details of the
algorithm are as follows.
Given an N by M gene expression data matrix, we perform the
k-means algorithm L times, with random initialization, to cluster
the N genes into k=2 clusters. Clustering results are arranged into
an N by L matrix, where the (i,j) element is the cluster assignment
of gene i in the j’th run of k-means. In order to draw the consensus
of the L runs of k-means, we apply k-means again based on the N
by L matrix, the collection of clustering results of the L runs, to
divide genes into two clusters. For each of the two clusters, the
coherence is computed as the average Pearson correlation between
each gene in the cluster and the cluster mean. If the coherence of a
cluster is higher than a pre-specified threshold c1, this cluster is
considered to be a coherent gene module. Otherwise, this cluster is
further partitioned by iterating the algorithm. After the iterative
process ends, we examine the resulting coherent modules
pairwisely. If the Pearson correlation of two modules’ centers is
higher than a pre-specified threshold c2, these two modules are
merged. This step iterates until no module-pair shares correlation
higher than c2. The stopping criterion of cluster coherence
guarantees that all resulting modules satisfy the pre-specified
coherence threshold c1. Modules that share correlation higher
than c2 are merged, so that the resulting gene modules are not
highly correlated with each other. We typically set the algorithm
parameters to the following values: L~200, c1~0:7, c2~0:9:
The purpose of our consensus k-means algorithm is to derive
coherent modules that are not highly correlated with each other.
Other clustering algorithms that achieve qualitatively similar
performance can be adopted as the clustering component of SPD.
When dealing with microarray gene expression data, without any
prior knowledge of gene modules and the underlying progression,
we find it helpful to cluster co-expressed genes into modules for the
purpose of dimension reduction. On the other hand, if we have
prior knowledge of predefined gene sets that describe pathways
whose progression similarities are of interest, we can use these
genes sets to supplement or replace the clustering results.
Sample Progression Discovery (SPD)
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SPD constructs minimum spanning trees (MSTs) based on
expression data of subsets of genes, i.e. gene modules. A MST is an
acyclic graph that connects all the samples using minimum total
edge weights. The weight on the edge that connects samples i and
j is defined as the Euclidean distance between the gene expression
of samples i and j. We use Boruvka’s algorithm [31] to construct
one MST based on each gene module. Briefly, we begin with a
disjoint graph with no edges, where each sample is one disjoint
component, and then iteratively add edges. In each iteration, we
randomly pick one of the smallest components, calculate its single
linkage Euclidean distances to all other components, and add an
edge that corresponds to the smallest single linkage distance. This
process iterates until all samples are connected.
Since the MST connects all the nodes using minimum total
edge weights, it tends to connect samples that are more similar to
each other. If we start from one sample and move along the edges
of the MST, we will observe a gradual change of gene expression.
Therefore, the MST reflects the progression among samples,
defined by the gradual change of the set of genes based on which
the MST is constructed.
Statistical concordance between modules and trees
The key step of SPD is the comparison between the expression
of gene modules and trees constructed from other modules. Given
the expression data of a gene module in M samples, we define an
M by M distance matrix D, where Dij is the Euclidean distance
between the gene expression profiles of samples i and j. Similarly,
a tree structure can also be summarized in a matrix form, which is
the adjacency matrix A, where Aij~1 if samples i and j are
directly connected in the tree; otherwise Aij~0. In SPD, we define
the concordance between a gene module and a tree as the
concordance between the distance matrix D and the adjacency
matrix A.
Typically, the statistical concordance between D and A includes
two aspects: (1) the distance between connected samples should be
small, and (2) the distance between not-connected samples should
be relatively larger [32]. In our analysis, we only focus on the
former aspect. Our rationale is that we want to model progressions
where the gene expression first drifts away from an initial state and
then comes back. One such example is the cell cycle. We define
the statistical concordance between a distance matrix D and an
adjacency matrix A as
s~
X
Aij~1
Dij ð1Þ
The meaning of s is the total edge weights jointly defined by the
gene module and the tree. If s is small, the gene module D and tree
structure A are concordant. Large s implies that the gene module
D and tree A are not concordant. In order to derive the p-value of
s, we perform random permutations. We randomly permute the
columns of the expression data, which is equivalent to reshuffling
the rows and columns of the distance matrix D. The p-value is the
probability of obtaining a smaller s during random permutations.
We typically perform 1000 permutations and use a p-value
threshold of 0.002 to determine whether a module and a tree are
sufficiently concordant.
Selecting modules that support common progression
Using Equation (1), we evaluate the statistical concordance
between all the gene modules and all the MSTs. Since each MST
is constructed based on one gene module, a MST and its
corresponding module are concordant by construction. If a
module is concordant with the MST derived from another
module, these two modules are similar in the sense that they
support a common progression pattern.
Based on the statistical concordance between all the modules
and all the MSTs, a progression similarity matrix is derived. The
(u,v) element of the progression similarity matrix is the number of
trees that are concordant with both modules u and v.F o r
visualization, we re-order the modules by hierarchical clustering
of the columns of the progression similarity matrix [14], so that
we can clearly identify similar modules along the diagonal, via
visual inspection. We explored several algorithms to automati-
cally identify similar modules from the progression similarity
matrix, including hierarchical clustering with gap statistics,
spectral partitioning, and forward and backward selection.
However, there was not a single algorithm and parameter setting
that performed well for all the datasets we analyzed. Since the
number of modules in the progression similarity matrix is usually
small, we decided to perform module selection manually. An
automated algorithm for this step will introduce an additional
parameter which is not as intuitive as manual selection. In the
progression similarity matrix, if there is a diagonal block whose
entries all have relatively high values, i.e. Figure 2(a) and (b), the
corresponding modules are similar because they describe a
common progression. SPD selects these similar modules, and
constructs an overall MST that describes the common progres-
sion supported by the selected modules, which is likely to be
biologically meaningful.
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